BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu Q, Liu T. Fibroblast growth factor receptor 4 polymorphisms and coronary artery disease: a case control study. Mol Biol Rep. 2012;39:8679-8685. [PMID: 22696188 DOI: 10.1007/s11033-012-1723-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Yin C, Li S, Zhao W, Guo Y, Zhang Y, Feng J. The role of fibroblast growth factor receptor 4 polymorphisms in the susceptibility and clinical features of ischemic stroke. Journal of Clinical Neuroscience 2014;21:246-9. [DOI: 10.1016/j.jocn.2013.04.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
2 Shen YY, Lu YC, Shen DP, Liu YJ, Su XY, Zhu GS, Yin XL, Ni XZ. Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients. World J Gastroenterol 2013; 19(28): 4568-4575 [PMID: 23901234 DOI: 10.3748/wjg.v19.i28.4568] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
3 Schwantes-An TH, Liu S, Stedman M, Decker BS, Wetherill L, Edenberg HJ, Vatta M, Foroud TM, Chertow GM, Moe SM. Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis. Am J Nephrol 2019;49:125-32. [PMID: 30669147 DOI: 10.1159/000496060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
4 Cha Z, Zang Y, Guo H, Gu H, Tu X, Song H, Qian B. RETRACTED ARTICLE: Fibroblast growth factor receptor 4 polymorphisms and the prognosis of non-Hodgkin lymphoma. Mol Biol Rep 2014;41:1165-70. [DOI: 10.1007/s11033-013-2963-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Fang HM, Tian G, Zhou LJ, Zhou HY, Fang YZ. FGFR4 genetic polymorphisms determine the chemotherapy response of Chinese patients with non-small cell lung cancer. Acta Pharmacol Sin 2013;34:549-54. [PMID: 23524567 DOI: 10.1038/aps.2012.206] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
6 Gao L, Feng Z, Li Q, Li L, Chen L, Xiao T. Fibroblast growth factor receptor 4 polymorphism is associated with increased risk and poor prognosis of non-Hodgkin's lymphoma. Tumour Biol. 2014;35:2997-3002. [PMID: 24248544 DOI: 10.1007/s13277-013-1386-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]